Invion (IVX.AX) Stock Price

Invion Price

ASX·CLOSED
0.04AUD+0.00 (+0.00 %)
Market closed

Over the last 18 years Invion grew revenue by 3.0% annually, reaching 3.69 M AUD. For Invion, the net margin of -152.3% is down versus -27.4% a few years ago. The stock trades about 16% above its 52-week low.

Invion stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Invion over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Invion stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Invion's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Invion Stock Price History
DateInvion Price
7/10/20260.04 AUD
7/9/20260.04 AUD
7/8/20260.03 AUD
7/7/20260.03 AUD
7/6/20260.03 AUD
7/3/20260.03 AUD
7/2/20260.03 AUD
7/1/20260.04 AUD
6/30/20260.04 AUD
6/29/20260.04 AUD
6/26/20260.04 AUD
6/25/20260.04 AUD
6/24/20260.04 AUD
6/23/20260.04 AUD
6/22/20260.04 AUD
6/19/20260.04 AUD
6/18/20260.04 AUD
6/17/20260.04 AUD
6/16/20260.04 AUD
6/15/20260.05 AUD
6/12/20260.04 AUD
6/11/20260.04 AUD
6/10/20260.05 AUD
6/9/20260.05 AUD
6/5/20260.05 AUD
6/4/20260.05 AUD
6/3/20260.05 AUD
6/2/20260.05 AUD
6/1/20260.04 AUD
5/29/20260.04 AUD
5/28/20260.05 AUD
5/27/20260.05 AUD
5/26/20260.05 AUD
5/25/20260.05 AUD
5/22/20260.05 AUD
5/21/20260.05 AUD
5/20/20260.05 AUD
5/19/20260.05 AUD
5/18/20260.05 AUD
5/15/20260.06 AUD
5/14/20260.06 AUD
5/13/20260.06 AUD
5/12/20260.06 AUD
5/11/20260.06 AUD
5/8/20260.06 AUD
5/7/20260.06 AUD
5/6/20260.06 AUD
5/5/20260.06 AUD
5/4/20260.06 AUD
5/1/20260.06 AUD
4/30/20260.06 AUD
4/29/20260.06 AUD
4/28/20260.06 AUD
4/27/20260.06 AUD
4/24/20260.06 AUD
4/23/20260.06 AUD
4/22/20260.06 AUD
4/21/20260.06 AUD
4/20/20260.06 AUD
4/17/20260.06 AUD
4/16/20260.06 AUD
4/15/20260.06 AUD
4/14/20260.06 AUD
4/13/20260.06 AUD
4/10/20260.07 AUD
4/9/20260.07 AUD
4/8/20260.07 AUD
4/7/20260.06 AUD
4/2/20260.07 AUD
4/1/20260.07 AUD
3/31/20260.07 AUD
3/30/20260.07 AUD
3/27/20260.08 AUD
3/26/20260.08 AUD
3/25/20260.08 AUD
3/24/20260.08 AUD
3/23/20260.08 AUD
3/20/20260.08 AUD
3/19/20260.08 AUD
3/18/20260.08 AUD
3/17/20260.08 AUD
3/16/20260.08 AUD
3/13/20260.08 AUD
3/12/20260.08 AUD
3/11/20260.08 AUD
3/10/20260.08 AUD
3/9/20260.08 AUD
3/6/20260.08 AUD
3/5/20260.08 AUD
3/4/20260.08 AUD
3/3/20260.08 AUD
3/2/20260.08 AUD
2/27/20260.08 AUD
2/26/20260.08 AUD
2/25/20260.08 AUD
2/24/20260.08 AUD
2/23/20260.08 AUD
2/20/20260.08 AUD
2/19/20260.08 AUD
2/18/20260.09 AUD
2/17/20260.09 AUD
2/16/20260.08 AUD
2/13/20260.08 AUD
2/12/20260.08 AUD
2/11/20260.08 AUD
2/10/20260.08 AUD
2/9/20260.08 AUD
2/6/20260.09 AUD
2/5/20260.08 AUD
2/4/20260.08 AUD
2/3/20260.08 AUD
2/2/20260.08 AUD
1/30/20260.09 AUD
1/29/20260.09 AUD
1/28/20260.09 AUD
1/27/20260.09 AUD
1/23/20260.09 AUD
1/22/20260.09 AUD
1/21/20260.09 AUD
1/20/20260.09 AUD
1/19/20260.09 AUD
1/16/20260.09 AUD
1/15/20260.09 AUD
1/14/20260.09 AUD
1/13/20260.09 AUD
1/12/20260.09 AUD
1/9/20260.09 AUD
1/8/20260.09 AUD
1/7/20260.09 AUD
1/6/20260.09 AUD
1/5/20260.09 AUD
1/2/20260.09 AUD
12/31/20250.09 AUD
12/30/20250.09 AUD
12/29/20250.09 AUD
12/24/20250.09 AUD
12/23/20250.09 AUD
12/22/20250.08 AUD
12/19/20250.08 AUD
12/18/20250.08 AUD
12/17/20250.09 AUD
12/16/20250.09 AUD
12/15/20250.09 AUD
12/12/20250.09 AUD
12/11/20250.09 AUD
12/10/20250.09 AUD
12/9/20250.09 AUD
12/8/20250.10 AUD
12/5/20250.09 AUD
12/4/20250.10 AUD
12/3/20250.10 AUD
12/2/20250.08 AUD
12/1/20250.08 AUD
11/28/20250.08 AUD
11/27/20250.08 AUD
11/26/20250.08 AUD
11/25/20250.08 AUD
11/24/20250.08 AUD
11/21/20250.08 AUD
11/20/20250.08 AUD
11/19/20250.08 AUD
11/18/20250.08 AUD
11/17/20250.08 AUD
11/14/20250.08 AUD
11/13/20250.08 AUD
11/12/20250.08 AUD
11/11/20250.08 AUD
11/10/20250.09 AUD
11/7/20250.09 AUD
11/6/20250.09 AUD
11/5/20250.09 AUD
11/4/20250.09 AUD
11/3/20250.09 AUD
10/31/20250.09 AUD
10/30/20250.09 AUD
10/29/20250.09 AUD
10/28/20250.09 AUD
10/27/20250.09 AUD
10/24/20250.09 AUD
10/23/20250.09 AUD
10/22/20250.09 AUD
10/21/20250.09 AUD
10/20/20250.10 AUD
10/17/20250.10 AUD
10/16/20250.10 AUD
10/15/20250.10 AUD
10/14/20250.10 AUD
10/13/20250.09 AUD
10/10/20250.10 AUD
10/9/20250.10 AUD
10/8/20250.10 AUD
10/7/20250.10 AUD
10/6/20250.10 AUD
10/3/20250.10 AUD
10/2/20250.10 AUD
10/1/20250.11 AUD
9/30/20250.10 AUD
9/29/20250.10 AUD
9/26/20250.11 AUD
9/25/20250.11 AUD
9/24/20250.11 AUD
9/23/20250.11 AUD
9/22/20250.12 AUD
9/19/20250.12 AUD
9/18/20250.12 AUD
9/17/20250.12 AUD
9/16/20250.12 AUD
9/15/20250.13 AUD
9/12/20250.13 AUD
9/11/20250.12 AUD
9/10/20250.12 AUD
9/9/20250.12 AUD
9/8/20250.13 AUD
9/5/20250.13 AUD
9/4/20250.13 AUD
9/3/20250.13 AUD
9/2/20250.13 AUD
9/1/20250.14 AUD
8/29/20250.13 AUD
8/28/20250.13 AUD
8/27/20250.13 AUD
8/26/20250.12 AUD
8/25/20250.12 AUD
8/22/20250.13 AUD
8/21/20250.12 AUD
8/20/20250.12 AUD
8/19/20250.14 AUD
8/18/20250.09 AUD
8/15/20250.09 AUD
8/14/20250.09 AUD
8/13/20250.09 AUD
8/12/20250.09 AUD
8/11/20250.09 AUD
8/8/20250.09 AUD
8/7/20250.10 AUD
8/6/20250.10 AUD
8/5/20250.10 AUD
8/4/20250.10 AUD
8/1/20250.10 AUD
7/31/20250.10 AUD
7/30/20250.10 AUD
7/29/20250.10 AUD
7/28/20250.10 AUD
7/25/20250.10 AUD
7/24/20250.09 AUD
7/23/20250.10 AUD
7/22/20250.10 AUD
7/21/20250.10 AUD
7/18/20250.11 AUD
7/17/20250.12 AUD
7/16/20250.11 AUD
7/15/20250.10 AUD
7/14/20250.10 AUD
Access this data via the Eulerpool API
Get Free API Key

Invion Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
737,700.00 AUD
-808,600.00 AUD
-4.87 M AUD
Jan 1, 2019
3.88 M AUD
-2.52 M AUD
-1.06 M AUD
Jan 1, 2020
3.48 M AUD
-1.03 M AUD
-953,900.00 AUD
Jan 1, 2021
2.33 M AUD
-1.57 M AUD
-1.48 M AUD
Jan 1, 2022
3.29 M AUD
-2.32 M AUD
-2.24 M AUD
Jan 1, 2023
4.10 M AUD
-1.61 M AUD
-1.61 M AUD
Jan 1, 2024
3.69 M AUD
-5.39 M AUD
-5.63 M AUD
Jan 1, 2025
0.00 AUD
-8.11 M AUD
-8.81 M AUD

Invion Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 12, 2026, 3:26 AM
 
REVENUEM AUD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEk AUD
NET INCOMEM AUD
NET INCOME GROWTH%
SHARESB
2010201120122013201420152016201720182019202020212022202320242025
–––––––––3.003.002.003.004.003.00–
–––––––––––-33.3350.0033.33-25.00–
–––––––––33.3333.3350.0033.3325.0033.33–
1,000.001,000.001,000.001,000.001,000.001,000.001,000.001,000.001,000.001,000.001,000.001,000.001,000.001,000.001,000.001,000.00
-16.00-13.00-5.00-5.00-6.00-13.00-4.00-2.00-4.00-1.00–-1.00-2.00-1.00-5.00-8.00
33.33-18.75-61.54–20.00116.67-69.23-50.00100.00-75.00––100.00-50.00400.0060.00
0.100.180.300.510.690.771.361.593.815.505.505.530.060.060.060.07
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Invion generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Invion retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Invion's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Invion has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Invion's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Invion stock margins

The Invion margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Invion. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Invion.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
29.48 %
-109.61 %
-660.17 %
Jan 1, 2019
29.48 %
-64.85 %
-27.41 %
Jan 1, 2020
29.48 %
-29.52 %
-27.44 %
Jan 1, 2021
34.81 %
-67.48 %
-63.65 %
Jan 1, 2022
29.44 %
-70.52 %
-68.09 %
Jan 1, 2023
29.48 %
-39.34 %
-39.34 %
Jan 1, 2024
29.48 %
-145.84 %
-152.34 %
Jan 1, 2025
29.48 %
- %
- %

Invion Stock Revenue, EBIT, Earnings per Share

The Invion earnings per share therefore indicates how much revenue Invion has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
0.00 AUD
-0.00 AUD
-0.00 AUD
Jan 1, 2019
0.00 AUD
-0.00 AUD
-0.00 AUD
Jan 1, 2020
0.00 AUD
-0.00 AUD
-0.00 AUD
Jan 1, 2021
0.00 AUD
-0.00 AUD
-0.00 AUD
Jan 1, 2022
0.05 AUD
-0.04 AUD
-0.04 AUD
Jan 1, 2023
0.06 AUD
-0.03 AUD
-0.03 AUD
Jan 1, 2024
0.06 AUD
-0.08 AUD
-0.09 AUD
Jan 1, 2025
0.00 AUD
-0.11 AUD
-0.12 AUD

Invion business model & stock analysis

Invion Ltd is an Australian company specializing in the development of treatment solutions for respiratory and inflammatory diseases. The company was originally founded in 2000 and is headquartered in Perth, Western Australia. It began as a company called CBio that focused on developing technology to prevent blood clot formation. In 2004, it was renamed Invion and shifted its focus to developing treatment solutions for respiratory and inflammatory diseases. Invion has acquired several pharmaceutical companies and has developed an innovative pipeline of products. The company is positioned as a biopharmaceutical company specializing in the discovery and development of treatments based on immunological research for the prevention, diagnosis, and treatment of severe respiratory and inflammatory diseases. It utilizes a combination of proprietary platform technology and internal expertise and collaborates with small and mid-sized pharmaceutical companies. Invion is divided into three main business divisions: antiviral treatment, immunomodulation, and diagnostics. In terms of products, Invion has several in development stages, including INV102 for severe asthma, INV103 for Covid-19, INV104 for lung inflammation, INV027 for COPD, and INV043 for allergic asthma. Overall, Invion aims to improve patient care and diagnosis in the respiratory and inflammatory disease space through innovative technologies.

Invion SWOT Analysis

Strengths

Invion Ltd has a diverse product portfolio, offering a range of innovative and effective solutions in various industries.

The company has a strong intellectual property portfolio and a team of experts with extensive knowledge and expertise.

Invion Ltd has established strategic partnerships and collaborations, allowing access to additional resources and opportunities for growth.

Weaknesses

The company is relatively small compared to some of its competitors, limiting its financial resources and market reach.

Invion Ltd may face challenges in terms of scalability and production capabilities as it expands its operations.

There might be a certain level of customer perception regarding the company's brand and reputation due to its size and market presence.

Opportunities

The growing demand for innovative solutions presents significant opportunities for Invion Ltd to expand its market share.

The company can leverage advancements in technology and research to develop new and improved products.

Exploring international markets and partnerships can help Invion Ltd tap into new customer segments and increase global presence.

Threats

Fluctuating economic conditions and market uncertainties may impact the demand for Invion Ltd's products.

Competitors with larger market shares and greater resources pose a threat to Invion Ltd's market position and growth prospects.

Regulatory changes and compliance requirements in the industries Invion Ltd operates in can create challenges and constraints.

Invion Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Invion historical P/E ratio, EBIT multiple, and P/S ratio

Invion annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Invion shares outstanding

The number of shares of Invion was 72.05 M in 2025. This indicates how many shares Invion is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
3.81 B Stocks
Jan 1, 2019
5.50 B Stocks
Jan 1, 2020
5.50 B Stocks
Jan 1, 2021
5.53 B Stocks
Jan 1, 2022
61.17 M Stocks
Jan 1, 2023
64.20 M Stocks
Jan 1, 2024
64.24 M Stocks
Jan 1, 2025
72.05 M Stocks

Invion stock splits

In Invion's history, there have been no stock splits.
Price targets and forecasts for Invion are not yet available.

Invion shareholder structure

% Name
7.93272%
Chew (Chiat Thian)
Chew (Chiat Thian)
4.46137%
Wu (Xiaoyi)
Wu (Xiaoyi)
3.95057%
Cho (Honsue)
Cho (Honsue)
3.78437%
NGPDT Greater China Ltd
NGPDT Greater China Ltd
3.78225%
Lin (Mei Jun)
Lin (Mei Jun)
3.11755%
ACSLNC Pty. Ltd.
ACSLNC Pty. Ltd.

Invion Executives and Management Board

TC

Mr. Thian Chew

Executive Chairman of the Board, Chief Executive Officer · since 2017

Compensation1.50 M AUD
AY

Mr. Alan Yamashita

Non-Executive Director

Compensation76,287.00 AUD
AB

Mr. Alistair Bennallack

Non-Executive Director

Compensation54,740.00 AUD
ML

Ms. Melanie Leydin

Company Secretary · since 2020

Invion Supply Chain

Frequently asked questions about Invion

Invion Ltd is a biotechnology company focused on the development of therapies for respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). The company's business model is centered around research and development of innovative treatments using their proprietary Photosoft™ platform technology. This platform enables the formulation of targeted therapies that can be delivered via inhalation, providing potential benefits for patients in terms of improved efficacy and reduced side effects. Through strategic partnerships and collaborations, Invion aims to commercialize its products globally and make a significant impact on the treatment of respiratory conditions.

All fundamentals and in-depth analysis of Invion

Our stock analysis for Invion stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Invion. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Invion Stock
Invion Revenue→
Invion Stock
Invion Net Income→
Invion Stock
Invion P/E→
Invion Stock
Invion P/S→
Invion Stock
Invion EBIT→
Invion Stock
Invion Dividend→
Invion Stock
Invion Directors Dealings→
Invion Stock
Invion Stocks→
Invion Stock
Invion Market capitalization→
Invion Stock
Invion Debt→
Invion Stock
Invion Liabilities→
Invion Stock
Invion Equity→
Invion Stock
Invion AAQS→
Invion Stock
Invion Employees→
Invion Stock
Invion ROE→
Invion Stock
Invion ROA→
Invion Stock
Invion ROCE→
Invion Stock
Invion News→
Invion Stock
Invion Analyst Price Targets→

Health Stocks

InvivydInvex TherapeuticsINVO FertilityInventurus Knowledge SolutionsInyxInventiva SaIO BiotechInventivaIOL Chemicals and PharmaceuticalsInventisBio CoIon Beam ApplicationsInventionmedAll Stocks A–Z →